Important Points to Consider During Practical Application and in the Validation Studies of SARC-F Tool to Screen Sarcopenia [Response to Letter]
Ewa Zasadzka, Anna Pieczyńska, Tomasz Trzmiel, Mariola Pawlaczyk Department of Geriatric Medicine and Gerontology, Poznan University of Medical Sciences, Pozna, PolandCorrespondence: Ewa Zasadzka Email ezasad@ump.edu.plWe are very thankful for the critical remarks given by Ozlem Yilmaz and Gulistan&...
Guardado en:
| Autores principales: | , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2020
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/211bcb5d7e5a4d419c2edfbadedb90e0 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:211bcb5d7e5a4d419c2edfbadedb90e0 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:211bcb5d7e5a4d419c2edfbadedb90e02021-12-02T10:15:55ZImportant Points to Consider During Practical Application and in the Validation Studies of SARC-F Tool to Screen Sarcopenia [Response to Letter]1178-1998https://doaj.org/article/211bcb5d7e5a4d419c2edfbadedb90e02020-06-01T00:00:00Zhttps://www.dovepress.com/response-polish-translation-and-validation-of-the-sarc-f-tool-for-the--peer-reviewed-article-CIAhttps://doaj.org/toc/1178-1998Ewa Zasadzka, Anna Pieczyńska, Tomasz Trzmiel, Mariola Pawlaczyk Department of Geriatric Medicine and Gerontology, Poznan University of Medical Sciences, Pozna, PolandCorrespondence: Ewa Zasadzka Email ezasad@ump.edu.plWe are very thankful for the critical remarks given by Ozlem Yilmaz and Gulistan Bahat and the interest of our article titled “Polish Translation and Validation of the SARC-F Tool for the Assessment of Sarcopenia”.We agree with Ozlem Yilmaz and Gulistan Bahat that in cases with clinically suspected sarcopenia the use of SARC-F is not mandatory/obligatory as the first diagnostic step, and therefore could be omitted in this group of patients. Answering the second problematic point we would like to explain that we decided to use 4.5 kg in the first question of the SARC-F questionnaire because this weight was used in previous publications presenting the validation results of the questionnaire.1,2 The weight of 3 bottles of still water (1.5 kg each) commonly bought in Poland seemed to be a clear and straightforward way of explaining the actual weight in question.View the original paper by Zasadzka and colleaguesThis is in response to the Letter to the EditorZasadzka EPieczyńska ATrzmiel TPawlaczyk MDove Medical PressarticleGeriatricsRC952-954.6ENClinical Interventions in Aging, Vol Volume 15, Pp 969-970 (2020) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Geriatrics RC952-954.6 |
| spellingShingle |
Geriatrics RC952-954.6 Zasadzka E Pieczyńska A Trzmiel T Pawlaczyk M Important Points to Consider During Practical Application and in the Validation Studies of SARC-F Tool to Screen Sarcopenia [Response to Letter] |
| description |
Ewa Zasadzka, Anna Pieczyńska, Tomasz Trzmiel, Mariola Pawlaczyk Department of Geriatric Medicine and Gerontology, Poznan University of Medical Sciences, Pozna, PolandCorrespondence: Ewa Zasadzka Email ezasad@ump.edu.plWe are very thankful for the critical remarks given by Ozlem Yilmaz and Gulistan Bahat and the interest of our article titled “Polish Translation and Validation of the SARC-F Tool for the Assessment of Sarcopenia”.We agree with Ozlem Yilmaz and Gulistan Bahat that in cases with clinically suspected sarcopenia the use of SARC-F is not mandatory/obligatory as the first diagnostic step, and therefore could be omitted in this group of patients. Answering the second problematic point we would like to explain that we decided to use 4.5 kg in the first question of the SARC-F questionnaire because this weight was used in previous publications presenting the validation results of the questionnaire.1,2 The weight of 3 bottles of still water (1.5 kg each) commonly bought in Poland seemed to be a clear and straightforward way of explaining the actual weight in question.View the original paper by Zasadzka and colleaguesThis is in response to the Letter to the Editor |
| format |
article |
| author |
Zasadzka E Pieczyńska A Trzmiel T Pawlaczyk M |
| author_facet |
Zasadzka E Pieczyńska A Trzmiel T Pawlaczyk M |
| author_sort |
Zasadzka E |
| title |
Important Points to Consider During Practical Application and in the Validation Studies of SARC-F Tool to Screen Sarcopenia [Response to Letter] |
| title_short |
Important Points to Consider During Practical Application and in the Validation Studies of SARC-F Tool to Screen Sarcopenia [Response to Letter] |
| title_full |
Important Points to Consider During Practical Application and in the Validation Studies of SARC-F Tool to Screen Sarcopenia [Response to Letter] |
| title_fullStr |
Important Points to Consider During Practical Application and in the Validation Studies of SARC-F Tool to Screen Sarcopenia [Response to Letter] |
| title_full_unstemmed |
Important Points to Consider During Practical Application and in the Validation Studies of SARC-F Tool to Screen Sarcopenia [Response to Letter] |
| title_sort |
important points to consider during practical application and in the validation studies of sarc-f tool to screen sarcopenia [response to letter] |
| publisher |
Dove Medical Press |
| publishDate |
2020 |
| url |
https://doaj.org/article/211bcb5d7e5a4d419c2edfbadedb90e0 |
| work_keys_str_mv |
AT zasadzkae importantpointstoconsiderduringpracticalapplicationandinthevalidationstudiesofsarcftooltoscreensarcopeniaresponsetoletter AT pieczynskaa importantpointstoconsiderduringpracticalapplicationandinthevalidationstudiesofsarcftooltoscreensarcopeniaresponsetoletter AT trzmielt importantpointstoconsiderduringpracticalapplicationandinthevalidationstudiesofsarcftooltoscreensarcopeniaresponsetoletter AT pawlaczykm importantpointstoconsiderduringpracticalapplicationandinthevalidationstudiesofsarcftooltoscreensarcopeniaresponsetoletter |
| _version_ |
1718397455628763136 |